Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
ENDOCYTE INC (ECYT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/31/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 12/27/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/21/2018 |
4
| MIDDLETON FRED A (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Gifted 83,860 shares
@ $0
Disposed/sold 110,189 shares
@ $24, valued at
$2.6M
Disposed/sold 3,300 shares
@ $24, valued at
$79.2k
Disposed/sold 1,017,304 shares
@ $24, valued at
$24.4M
Disposed/sold 1,212,413 shares
@ $24, valued at
$29.1M
Disposed/sold 267,491 shares
@ $24, valued at
$6.4M
Disposed/sold 249,148 shares
@ $24, valued at
$6M
Disposed/sold 162,170 shares
@ $24, valued at
$3.9M
Disposed/sold 113,315 shares
@ $24, valued at
$2.7M
Disposed/sold 100,828 shares
@ $24, valued at
$2.4M
Disposed/sold 10,049 shares
@ $24, valued at
$241.2k
|
|
| 12/21/2018 |
4
| Machado Patrick (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 1,250 shares
@ $24, valued at
$30k
Disposed/sold 2,500 shares
@ $24, valued at
$60k
Disposed/sold 3,300 shares
@ $24, valued at
$79.2k
Disposed/sold 22,500 options to buy
@ $4.2, valued at
$94.5k
Disposed/sold 19,500 options to buy
@ $10.81, valued at
$210.8k
|
|
| 12/21/2018 |
4
| McAvoy David R. (General Counsel) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 2,119 shares
@ $24, valued at
$50.9k
Disposed/sold 23,750 shares
@ $24, valued at
$570k
Disposed/sold 37,500 options to buy
@ $2.96, valued at
$111k
|
|
| 12/21/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 164,256 shares
@ $24, valued at
$3.9M
Disposed/sold 4,375 shares
@ $24, valued at
$105k
Disposed/sold 13,125 shares
@ $24, valued at
$315k
Disposed/sold 20,000 shares
@ $24, valued at
$480k
Disposed/sold 22,500 shares
@ $24, valued at
$540k
Disposed/sold 27,500 options to buy
@ $9.05, valued at
$248.9k
Disposed/sold 59,996 options to buy
@ $3.55, valued at
$213k
Disposed/sold 70,000 options to buy
@ $9.86, valued at
$690.2k
Disposed/sold 45,000 options to buy
@ $11.11, valued at
$500k
Disposed/sold 52,498 options to buy
@ $5.1, valued at
$267.7k
Disposed/sold 52,498 options to buy
@ $3.18, valued at
$166.9k
|
|
| 12/21/2018 |
4
| Armour Alison A. (Chief Medical Officer) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Gifted 10,500 shares
@ $0
Gifted 10,500 shares
@ $0
Disposed/sold 72,253 shares
@ $24, valued at
$1.7M
Disposed/sold 10,500 shares
@ $24, valued at
$252k
Disposed/sold 5,000 shares
@ $24, valued at
$120k
Disposed/sold 15,000 shares
@ $24, valued at
$360k
Disposed/sold 20,000 shares
@ $24, valued at
$480k
Disposed/sold 22,500 shares
@ $24, valued at
$540k
Disposed/sold 25,000 options to buy
@ $5.16, valued at
$129k
Disposed/sold 45,788 options to buy
@ $3.18, valued at
$145.6k
Disposed/sold 39,999 options to buy
@ $2.16, valued at
$86.4k
|
|
| 12/21/2018 |
4
| Parker Katherine (VP of Human Resources) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Gifted 8,229 shares
@ $0
Disposed/sold 22,797 shares
@ $24, valued at
$547.1k
Disposed/sold 3,125 shares
@ $24, valued at
$75k
Disposed/sold 9,375 shares
@ $24, valued at
$225k
Disposed/sold 15,000 shares
@ $24, valued at
$360k
Disposed/sold 12,500 shares
@ $24, valued at
$300k
Disposed/sold 1,200 shares
@ $24, valued at
$28.8k
Disposed/sold 19,000 options to buy
@ $11.47, valued at
$217.9k
Disposed/sold 60,000 options to buy
@ $5.1, valued at
$306k
Disposed/sold 37,500 options to buy
@ $3.18, valued at
$119.3k
Disposed/sold 25,000 options to buy
@ $2.16, valued at
$54k
|
|
| 12/21/2018 |
4
| Russell Lesley (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 7,800 shares
@ $24, valued at
$187.2k
Disposed/sold 3,300 shares
@ $24, valued at
$79.2k
Disposed/sold 28,000 options to buy
@ $9.63, valued at
$269.6k
Disposed/sold 14,000 options to buy
@ $12.94, valued at
$181.2k
Disposed/sold 14,000 options to buy
@ $6.69, valued at
$93.7k
Disposed/sold 13,500 options to buy
@ $6.02, valued at
$81.3k
Disposed/sold 13,500 options to buy
@ $3.35, valued at
$45.2k
Disposed/sold 19,500 options to buy
@ $2.27, valued at
$44.3k
Disposed/sold 19,500 options to buy
@ $10.81, valued at
$210.8k
|
|
| 12/21/2018 |
4
| Chelius Erik C. (Vice President CMC) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 15,848 shares
@ $24, valued at
$380.4k
Disposed/sold 3,516 shares
@ $24, valued at
$84.4k
Disposed/sold 4,281 shares
@ $24, valued at
$102.7k
Disposed/sold 10,000 shares
@ $24, valued at
$240k
Disposed/sold 16,250 shares
@ $24, valued at
$390k
Disposed/sold 14,000 options to buy
@ $3.64, valued at
$51k
Disposed/sold 15,500 options to buy
@ $9.86, valued at
$152.8k
Disposed/sold 10,850 options to buy
@ $11.11, valued at
$120.5k
Disposed/sold 11,568 options to buy
@ $5.1, valued at
$59k
Disposed/sold 14,062 options to buy
@ $3.18, valued at
$44.7k
Disposed/sold 11,413 options to buy
@ $2.16, valued at
$24.7k
|
|
| 12/21/2018 |
4
| APLIN JOHN C (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 28,863 shares
@ $24, valued at
$692.7k
Disposed/sold 3,300 shares
@ $24, valued at
$79.2k
Disposed/sold 15,706 options to buy
@ $6, valued at
$94.2k
Disposed/sold 10,000 options to buy
@ $11.8, valued at
$118k
Disposed/sold 10,000 options to buy
@ $6.43, valued at
$64.3k
Disposed/sold 14,000 options to buy
@ $12.94, valued at
$181.2k
Disposed/sold 14,000 options to buy
@ $6.69, valued at
$93.7k
Disposed/sold 13,500 options to buy
@ $6.02, valued at
$81.3k
Disposed/sold 13,500 options to buy
@ $3.35, valued at
$45.2k
Disposed/sold 19,500 options to buy
@ $2.27, valued at
$44.3k
Disposed/sold 19,500 options to buy
@ $10.81, valued at
$210.8k
|
|
| 12/21/2018 |
4
| Taylor Beth (VP Finance & Chief Acctg Off) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 59,509 shares
@ $24, valued at
$1.4M
Disposed/sold 1,250 shares
@ $24, valued at
$30k
Disposed/sold 1,875 shares
@ $24, valued at
$45k
Disposed/sold 7,500 shares
@ $24, valued at
$180k
Disposed/sold 15,000 shares
@ $24, valued at
$360k
Disposed/sold 12,500 shares
@ $24, valued at
$300k
Disposed/sold 23,560 options to buy
@ $7.41, valued at
$174.6k
Disposed/sold 9,132 options to buy
@ $9.86, valued at
$90k
Disposed/sold 10,850 options to buy
@ $11.11, valued at
$120.5k
Disposed/sold 3,750 options to buy
@ $3.18, valued at
$11.9k
Disposed/sold 12,969 options to buy
@ $3.21, valued at
$41.6k
|
|
| 12/21/2018 |
4
| GODDARD COLIN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 7,800 shares
@ $24, valued at
$187.2k
Disposed/sold 3,300 shares
@ $24, valued at
$79.2k
Disposed/sold 28,000 options to buy
@ $10.37, valued at
$290.4k
Disposed/sold 14,000 options to buy
@ $6.69, valued at
$93.7k
Disposed/sold 13,500 options to buy
@ $6.02, valued at
$81.3k
Disposed/sold 13,500 options to buy
@ $3.35, valued at
$45.2k
Disposed/sold 19,500 options to buy
@ $2.27, valued at
$44.3k
Disposed/sold 19,500 options to buy
@ $10.81, valued at
$210.8k
|
|
| 12/21/2018 |
4
| Svoronos Dawn (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 3,750 shares
@ $24, valued at
$90k
Disposed/sold 3,300 shares
@ $24, valued at
$79.2k
Disposed/sold 22,500 options to buy
@ $10.81, valued at
$243.2k
Disposed/sold 19,500 options to buy
@ $10.81, valued at
$210.8k
|
|
| 12/21/2018 |
4
| KOZIN MARC D (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 7,800 shares
@ $24, valued at
$187.2k
Disposed/sold 3,300 shares
@ $24, valued at
$79.2k
Disposed/sold 20,000 options to buy
@ $7.71, valued at
$154.2k
Disposed/sold 14,000 options to buy
@ $12.94, valued at
$181.2k
Disposed/sold 14,000 options to buy
@ $6.69, valued at
$93.7k
Disposed/sold 13,500 options to buy
@ $6.02, valued at
$81.3k
Disposed/sold 13,500 options to buy
@ $3.35, valued at
$45.2k
Disposed/sold 19,500 options to buy
@ $2.27, valued at
$44.3k
Disposed/sold 19,500 options to buy
@ $10.81, valued at
$210.8k
|
|
| 12/21/2018 |
4
| Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 243,739 shares
@ $24, valued at
$5.8M
Disposed/sold 19,919 shares
@ $24, valued at
$478.1k
Disposed/sold 7,188 shares
@ $24, valued at
$172.5k
Disposed/sold 5,000 shares
@ $24, valued at
$120k
Disposed/sold 23,438 shares
@ $24, valued at
$562.5k
Disposed/sold 62,500 shares
@ $24, valued at
$1.5M
Disposed/sold 37,500 shares
@ $24, valued at
$900k
Disposed/sold 20,800 options to buy
@ $9.05, valued at
$188.2k
Disposed/sold 74,998 options to buy
@ $3.55, valued at
$266.2k
Disposed/sold 58,719 options to buy
@ $9.86, valued at
$579k
Disposed/sold 36,000 options to buy
@ $11.11, valued at
$400k
|
|
| 12/21/2018 |
4
| Low Philip S (Chief Science Officer) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 349,944 shares
@ $24, valued at
$8.4M
Disposed/sold 132,473 shares
@ $24, valued at
$3.2M
Disposed/sold 4,375 shares
@ $24, valued at
$105k
Disposed/sold 13,125 shares
@ $24, valued at
$315k
Disposed/sold 20,000 shares
@ $24, valued at
$480k
Disposed/sold 22,500 shares
@ $24, valued at
$540k
Disposed/sold 13,570 options to buy
@ $3.82, valued at
$51.8k
Disposed/sold 8,560 options to buy
@ $9.05, valued at
$77.5k
Disposed/sold 17,950 options to buy
@ $11.8, valued at
$211.8k
Disposed/sold 59,996 options to buy
@ $3.55, valued at
$213k
Disposed/sold 56,918 options to buy
@ $9.86, valued at
$561.2k
|
|
| 12/21/2018 |
4
| Andriole Michael T. (CFO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 52,582 shares
@ $24, valued at
$1.3M
Disposed/sold 37,500 shares
@ $24, valued at
$900k
Disposed/sold 25,000 shares
@ $24, valued at
$600k
Disposed/sold 75,000 options to buy
@ $2.22, valued at
$166.5k
Disposed/sold 50,000 options to buy
@ $3.01, valued at
$150.5k
|
|
| 12/21/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/21/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/21/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/21/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/21/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/21/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/21/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/21/2018 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 12/21/2018 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 12/21/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 12/20/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/20/2018 |
GN
| Endocyte Stockholders Approve Merger Agreement with Novartis AG |
| 12/19/2018 |
4
| Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Gifted 2,500 shares
@ $0
Gifted 1,250 shares
@ $0
Gifted 3,186 shares
@ $0
Gifted 1,250 shares
@ $0
Exercised 16,073 options to buy
@ $3.55, valued at
$57.1k
Exercised 5,500 options to buy
@ $9.86, valued at
$54.2k
Exercised 9,000 options to buy
@ $5.1, valued at
$45.9k
Exercised 3,750 options to buy
@ $3.18, valued at
$11.9k
Exercised 9,531 options to buy
@ $3.21, valued at
$30.6k
Exercised 5,000 options to buy
@ $2.16, valued at
$10.8k
|
|
| 12/19/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Exercised 20,000 options to buy
@ $2.54, valued at
$50.8k
Exercised 26,177 options to buy
@ $3.82, valued at
$100k
Exercised 13,089 options to buy
@ $7.49, valued at
$98k
Exercised 22,500 options to buy
@ $9.05, valued at
$203.6k
Exercised 20,004 options to buy
@ $3.55, valued at
$71k
Exercised 2 options to buy
@ $5.1, valued at
$10.2
Exercised 2 options to buy
@ $3.18, valued at
$6.4 |
|
| 12/19/2018 |
4
| Andriole Michael T. (CFO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Gifted 4,500 shares
@ $0
Exercised 25,000 options to buy
@ $2.22, valued at
$55.5k
|
|
|
|
|